Skip to main content

Immunohistochemical analysis of sensory corpuscles in human transplants of the anterior cruciate ligament



Sensory nerve endings in ligaments play an important role for the proprioceptive function. Clinical trials show that the sense of body position does not fully recover in the knee joint after reconstructive surgery of the ruptured anterior cruciate ligament. The aim of this study is to identify sensory corpuscles in autogenous and allogenous transplants of the ligament and to compare their quantity between the used allografts and autografts.


Thirty-three patients were included in this study. Three patellar tendon allografts, 14 patellar tendon autografts and 12 semitendinosus autografts were harvested during revision surgery after traumatic rerupture of the graft. The control consisted of 4 healthy anterior cruciate ligaments after fresh rupture. After haematoxylin staining, immunohistochemical analysis was performed using antibodies against S100, p75 and PGP9.5. Microscopical examination was carried out, and the number of mechanoreceptors was counted. Statistical analysis was performed using the Mann-Whitney U test.


Two types of mechanoreceptors were identified in each graft: Ruffini corpuscles and free nerve endings. The number of Ruffini corpuscles per square centimeter was the highest in the control. Comparing the grafts, the highest number of receptors could be detected in the semitendinosus autograft. The amount of free nerve endings was higher in the semitendinosus and patellar tendon autografts than in the control; the allografts showed the lowest number of receptors. With increasing time after reconstruction, the number of both types of receptors showed a decrease in the semitendinosus graft, whereas it increased in the patellar tendon graft and allograft. The number of mechanoreceptors in the semitendinosus and patellar tendon graft decreased over time after graft-failure, whereas it increased slightly in the allograft.


This study was the first to identify mechanoreceptors in human transplants of the anterior cruciate ligament. The partial increase in the number of receptors over time after reconstruction could indicate a reinnervation of the grafts.


The rupture of the anterior cruciate ligament mainly affects young, physically active people and is the most common injury of the knee [1]. To regain full function of the joint reconstruction of the ligament is the therapy of choice [2]. Currently, the most popular procedure is the use of a free, multi-stranded semitendinosus transplant [3]. An alternative method is the replacement with a quadriceps tendon graft or a patellar tendon graft which is removed with bone parts from patella and tibia [4]. Allografts from Achilles, quadriceps or patellar tendon are rarely used today due to risk of infection and uncertainty regarding long-term survival [5].

In a meta-analysis, Kim et al. showed that the proprioceptive function in the knee joint with ruptured anterior cruciate ligament is worse than in the healthy contralateral knee [6]. After reconstructive surgery, proprioception approximates the original state, as multiple clinical trials have shown [7,8,9], but it remains to be clarified whether this improvement is due to reinnervation of the graft or to re-establishment of proprioception by peri-articular structures. For this reason, the investigation of mechanoreceptors in transplants of ligaments is of great importance. The presence of these receptors is a necessity for proprioceptive sensation. At the time of this study, there were only few histological investigations of human cruciate ligament grafts. Young et al. carried out an immunohistochemical investigation of grafts regarding their neuronal structure in 2016. They took samples from ten patients who required either revision surgery or knee arthroscopy due to a different pathology. Four bone-tendon-bone patellar (BTBP) autografts, five BPTB allografts, one hamstring autograft and one healthy anterior cruciate ligament were stained with a monoclonal antibody against neurofilament protein (NFP) and then examined under a light microscope for positive structures. The authors described significantly fewer neuronal structures in the grafts compared to the control, whereas no significant difference could be observed within the graft groups [10]. Kim et al. found no mechanoreceptors in the examination of eleven Achilles tendon allografts, which they attributed to the fact that there is no significant reinnervation in the transplants [11].

In summary, there is no consensus concerning the presence of mechanoreceptors in transplants of the anterior cruciate ligament. Furthermore, it remains unclear whether there could be a reinnervation process after reconstruction of the ligament. For this reason, the aim of this study was to morphologically identify mechanoreceptors in the examined grafts and to correlate them with clinical parameters to obtain evidence of a possible reinnervation.

Materials and methods


Thirty-three samples were taken between 2007 and 2012 during revision surgery after graft failure or initial surgery for reconstruction of the anterior cruciate ligament. In two cases, samples were harvested during implantation of a total knee replacement. The mean age of the patients (23 men and 10 women) at the time of surgery was 31 years (range 17–74 years). Transplant groups were subdivided according to the length of stay and time from rerupture to revision surgery. The length of stay describes the time from implantation to rerupture of the graft. Exact numbers are shown in Table 1.

Table 1 Number of specimens in the control group and the graft groups. Graft groups are further divided in length of stay and time from rerupture to revision surgery

Immunohistochemical staining

Immediately after harvesting the specimens were fixed in 4% buffered formalin solution and embedded in paraffin. The number of sections to be made in each plane of the specimens was based on the size of the mechanoreceptors: Since a single receptor can extend over some 7 μm cuts, the distance between the cut planes was set to 70 μm. This procedure allows the number of receptors counted more than once to be kept very low [12]. One plane therefore consists of 10 sections; a total of 6 planes (A–F) were cut per sample as shown in Fig. 1.

Fig. 1
figure 1

Sketch of the sectional planes A–F of one specimen. One plane equals 70 μm

In each of the planes, the first specimen was stained with HE, the second one with polyclonal antibody against S100 (abcam, ab15520), the third one with polyclonal antibody against p75 (sigmaaldrich, N3908) and the fourth one with monoclonal antibody against PGP9.5 (abcam, ab8189). These three antibodies are widely used in immunohistochemical analysis of neuronal structures and have proven to be the most reliant method in the detection of mechanoreceptors [11, 13,14,15].


The S100-protein is expressed in myelinated and non-myelinated Schwann cells of the peripheral nervous system and in sensory neuronal structures such as mechanoreceptors [16]. It plays an important role in the intracellular calcium homeostasis; the organization of the cytoskeleton and some of the S100 proteins are segregated and fulfil extracellular functions which are similar to cytokines [17, 18].

The p75-receptor is part of the TNF-receptor family [19]. Like the others of these receptors, it induces apoptosis of the cell. Furthermore, there are other functions of the receptor which are subject of current research such as migration of Schwann cells, regulation of sensory neurons and myelinisation [20]. The p75-receptor is expressed both in myelinated and non-myelinated neurons [21].

Protein-Gene-Product 9.5 is a ubiquitin-carboxyl-hydroxylase, also known as UCH-L1 [22, 23]. Although it does not only occur in neuronal tissue, its concentration is up to 50 times higher in neurons. On the one hand, it is responsible for ubiquitination which marks damaged proteins and leads to their degradation [24]. On the other hand, it is assumed to play an important role in differentiation and growth of neuronal cells and synapses [25].

The slides were deparaffinized with xylene (3 × 10 min) and hydrated through incubation in an increasing alcohol sequence (100 °C, 2 × 96 °C, 70 °C each for 10 min, H2O dest. for 5 min). Subsequently, the antigens had to be demasked for the anti-p75 and anti-PGP9.5 staining by incubation in citrate buffer at 95 °C for 40 min. Afterwards, each specimen was incubated with 3% H2O2 for 10 min to block endogenous peroxidase. Blocking solution then was applied to the slides for 5 min before they were incubated with the primary antibody overnight in a wet chamber at 4 °C (dilutions: anti-S100: 1/100, anti-p75: 1/200, anti-PGP9.5: 1/250). Human malignant melanoma was used as positive control for the anti-S100 antibody, neonatal brain of the rat for the anti-p75 antibody and neonatal pancreas of the rat for the anti-PGP9.5 antibody. After removal of the antibodies, postblocking solution was applied for 20 min, before the slides were incubated with the secondary antibody (horseradish-peroxidase polymer, HRP) for 30 min. Between each step, the slides were rinsed with phosphate-buffered saline (PBS) 3 times. Following, they were developed in aminoethyl carbazole (AEC) for 10 min (anti-S100), respectively, and 15 min (anti-p75 and anti-PGP9.5). The reaction between the HRP and AEC was then stopped with H2O dest., and counterstaining with Mayer’s HTX (5 min) was performed. After rinsing with tap water for 10 min, the slides were fixed with aqueous mounting medium.

Histological examination

The histological examination of the stained sections was performed by the first author (D.R.); randomized samples were examined by a second investigator (A.B.). First, overview images were taken using an Olympus BX53 light microscope to measure the area of the sections. Mechanoreceptors were analysed according to the classification of Freeman and Wyke. This classification consists of four types of receptors: I, Ruffini-endings; II, Pacinian-corpuscles; III, Golgi-like endings; and IV, free nerve endings [26]. Mechanoreceptors were counted through an Olympus BX 51 light microscope in every slide stained with immunohistochemistry, which means three slides per section in six sections per specimen. The number of receptors was then stated per square centimeter. Due to the high reliability, the number counted in the sections stained with the anti-S100 antibody was used to determine the number of receptors per square centimeter [12, 16]. Sections stained with the other antibodies were used to clearly identify each receptor.

Data are given as mean ± standard deviation. The IBM SPSS statistics program (version 24, IBM Corporation) was used for statistical evaluation. Since the results were not normally distributed, data were analysed using the Mann-Whitney U test to compare the independent samples. A p < 0.05 was considered statistically significant. The number of mechanoreceptors per square centimeter compared to the native ACL was set as the primary endpoint.


When the samples were taken, important information about the clinical status of the joint and accompanying injuries could be collected intraoperatively. To put the results shown below into a clinical context, these findings as well as the age of the patients are presented in Table 2.

Table 2 Clinical data provided by the surgeon (H.O.M.), obtained through intraoperative examination of the joint and mean age of the patients with range in years

Two types of mechanoreceptors could be detected in each of the investigated graft groups and the control group: Ruffini endings (type I) and free nerve endings (type IV). Pictures of these receptors stained with the anti-S100 antibody are shown in Fig. 2. Pacini corpuscles or Golgi endings could not be detected in any of the slides. Pictures of these receptors stained with the anti-PGP9.5 and anti-p75 antibody can be found in the additional files (additional files 1 and 2).

Fig. 2
figure 2

Ruffini ending (a) and free nerve ending (b). Staining with the anti-S100 antibody

The control showed 8.88 (± 16.27) Ruffini endings and 23.69 (± 31.97) free nerve endings per square centimeter. With 4.88 (± 5.27) type I receptors and 37.87 (± 27.90) type IV receptors per square centimeter, the number of mechanoreceptors was the highest in the investigated semitendinosus autografts. The patellar tendon autografts showed a lower number of receptors with 2.56 (± 5.24) Ruffini endings and 37.03 (± 28.02) free nerve endings per square centimeter. The lowest number of receptors was detected in the three investigated patellar tendon allografts with 1.53 (± 1.34) type I receptors and 10.65 (± 9.32) type IV receptors per square centimeter (Fig. 3).

Fig. 3
figure 3

Distribution of mechanoreceptors in the control group (CG) and the graft groups (AG, patellar tendon allograft; STG, semitendinosus autograft; PTG, patellar tendon autograft) determined with the anti-S100 antibody. Asterisk (*) indicates significant difference in the number of free nerve endings between AG and STG (p = 0.048)

The difference in the number of free nerve endings between the patellar tendon allografts and the semitendinosus autografts showed a statistical significance (p = 0.048).

To gain insight into a possible reinnervation of the transplants, the graft groups were subdivided according to the length of their stay in the joint. The periods of time in which the groups were divided as well as the number of receptors found in each group are shown in Table 3.

Table 3 Number of specimens per time period (length of stay between implantation and rerupture) and numbers for Ruffini endings and free nerve endings per square centimeter for each time period

With increasing time from implantation, the mechanoreceptors especially in the patellar tendon autografts showed an increase in their number for both Ruffini endings (0.74 ± 1.27 ➔ 1.89 ± 3.18 ➔ 6.19 ± 10.72 per cm2) and free nerve endings (20.38 ± 11.57 ➔ 33.01 ± 33.93 ➔ 64.40 ± 60.22 per cm2). The semitendinosus grafts showed a decreasing number of free nerve endings after 120 months (55.10 ± 35.36 ➔ 32.78 ± 29.56 ➔ 25.72 ± 10.15 per cm2) and an inconclusive development in the number of Ruffini endings (7.03 ± 7.98 ➔ 2.71 ± 3.56 ➔ 4.88 ± 3.63 cm2). Since the number of samples for the allografts was only three, there were no reliable results.

Furthermore, the number of receptors could be analysed concerning the time from rerupture of the graft until revision surgery. Two groups were set up for this purpose: grafts which stayed less than 100 days in the joint after rerupture and grafts which stayed longer than 100 days. The number of specimens and mechanoreceptors per group is shown in Table 4. For two patients with a semitendinosus graft information about this period could not be obtained.

Table 4 Number of specimens per time period between rerupture and revision surgery and numbers for Ruffini endings and free nerve endings per square centimeter for each time period

Generally, it has been shown that the number of receptors decreases with increasing time from rerupture. In the investigated semitendinosus grafts, the number of receptors in the second group was less than half compared to the first one (6.43 ± 6.41 ➔ 2.50 ± 2.15 per cm2) whereas the number of free nerve endings only showed a slight decrease (42.38 ± 34.14 ➔ 41.09 ± 23.77 per cm2). These findings were even more evident in the patellar tendon autografts, where both Ruffini endings (4.92 ± 7.62 ➔ 0.80 ± 1.13 per cm2) and free nerve endings (64.89 ± 44.64 ➔ 16.13 ± 9.79 per cm2) showed a clear decrease. The development for the free nerve endings showed a statistical significance (p = 0.039). Again, no reliable results for the allografts could be obtained due to the low number of specimens.


For the first time, this study could prove the existence of mechanoreceptors in human transplants of the anterior cruciate ligament. Ruffini endings and free nerve endings could be identified in every graft group. The previously mentioned study of Young et al. also found neuronal structures both in patellar tendon allo- and autograft and in hamstring autografts. The authors described a significantly lower number of NFP-positive structure in the transplant groups compared to the control group. They did not find a difference between the transplant groups [10]. In this study, the number of Ruffini endings was also lower in the graft groups, but the difference to the control showed no statistical significance.

Multiple studies on animals have already shown mechanoreceptors in transplants of the anterior cruciate ligament: Barrack et al. not only found types I, II and IV receptors in patellar tendon autografts in dogs but also derived sensory evoked potentials (SEP) by stimulating the grafts [27]. Samples taken as biopsies from human Achilles tendon allografts and stained with the anti-S100 antibody on the other hand did not show any sensory nerve endings [6, 15]. An explanation for the different results could be the removal technique and the different original tissues.

The increasing number of receptors in the patellar tendon grafts with a longer time of stay in the joint could be a sign of reinnervation. These findings also were previously shown in animal experiments. Fromm and Kummer could prove that ACL allografts in canines show significantly more nerve endings 24 and 36 weeks after implantation than after 12 weeks [28]. Wada et al. compared the number of Ruffini endings in patellar tendon autografts in canines with the number of receptors in the contralateral anterior cruciate ligament. Twenty weeks after implantation, there was no statistical significance between the control group and the transplant group. The authors considered this as a sign for a reinnervation of the grafts [29]. Further studies on human transplants are needed to prove the reinnervation of the transplants.

In the present study, the development of the receptors after rupture of the grafts could be described for the first time; there are no data in the literature describing this process. The number of sensory corpuscles in the remnants of the ruptured ACL on the other hand has already been extensively investigated: a meta-analysis by Kosy et al. from 2017 describes that the decrease in mechanoreceptors with increasing time from rupture could be demonstrated in multiple histological studies [30]. A microscopic examination of the ruptured ACL from Murray et al. showed an increase of blood vessels and cell count 8 to 20 weeks after rupture [31]. Thus, the decrease of sensory corpuscles after rupture of the grafts presented in this study seems to be similar to the one in remnants of the ruptured ACL. There is no evidence that the development of nerve endings corresponds to the increase of blood vessels and cell count.

To compare the number of sensory nerve endings between the grafts and the original tendons (patellar tendon and semitendinosus tendon), data from the literature was used. Çabuk et al. investigated all ligaments of the human knee concerning mechanoreceptors by using an antibody against S100 [32]. Table 5 shows the numbers for the original tissue as found by the authors compared with the data for the grafts as obtained in this study.

Table 5 Numbers of mechanoreceptors per square centimeter in the graft groups, the control group and the original tendons. Staining with the anti-S100 antibody 

In general, the number of mechanoreceptors is higher in all the investigated grafts compared to the original tendons. This difference becomes particularly clear for the semitendinosus graft, but even the patellar tendon allograft showed more Ruffini endings than the native patellar tendon. Furthermore, the results for the graft groups are closer to the control than to the ones for the original tendons. These results are not statistically significant, so they can only be regarded as a tendency. A meta-analysis by Pauzenberger et al. concerning the remodelling of ACL grafts showed that multiple studies on animals and humans could prove an approximation in the structure of the transplants towards the ACL [33]. The investigated parameters included cellularity, vascularity, myofibroblast density and collagen orientation [34]. Numbers for the mechanoreceptors in the transplants as shown in Table 5 could be a sign of remodelling also in regard of sensory nerve endings. A clinical trial by Ozenci et al. could prove significantly better proprioception after reconstruction of the ACL in comparison to the injured ACL using the threshold to detect passive motion test (TDPM). The authors did not find any difference between autograft and allograft [9]. The results of the present study indicate a superiority of autografts over allografts concerning the number of mechanoreceptors, which could become an important factor in graft choice. In order to place these findings in a clinical context, it is necessary to consider the status of the examined joints and the accompanying injuries, which occurred during the traumatic rupture. Exact numbers are shown in Table 2, which is why only the most important insights should be stated here. More than half of the joints in the transplant groups showed at least signs of initial gonarthrosis (STG, 58%; PTG, 64%; AG, 67%), whereas the controls did not show any sign of arthrosis. The risk of developing arthrosis after rupture and reconstruction of the ACL is a known fact investigated in many studies [35, 36], which could be an explanation for the occurrence of osteoarthritis in the transplant groups. Furthermore, cartilage lesions were found in nearly every joint with an ACL transplant; a damage of the medial meniscus could be described in nearly half of the cases after rupture of the semitendinosus or patellar tendon autograft. In contrast, the control group showed mostly no cartilage damage. Accompanying lesions such as rupture of the MCL or tibial plateau fracture were rarely seen.


There are some limitations to be considered looking at the results of this study. First, the population of which the samples were taken was inhomogeneous. For this reason, clinical parameters could not be correlated with the number of receptors. Furthermore, the control consisted of traumatically ruptured ACL; no healthy native tissue could be included in this study. Therefore, the anatomic localisation of receptors could not be shown.


This study was the first to identify mechanoreceptors in human transplants of the anterior cruciate ligament. The partial increase in the number of receptors over time after reconstruction could indicate a reinnervation of the grafts. Two types of mechanoreceptors could be identified in the investigated allo- and autografts as well as the control group. There was a significant difference for the free nerve endings between semitendinosus autograft and patellar tendon allograft. Grafts with a longer length of stay showed more mechanoreceptors; this could indicate a possible reinnervation. After rerupture, the number of sensory nerve ending was decreasing with increasing time. The number of receptors in the grafts was higher than in the original tendons (patellar tendon and semitendinosus tendon), which could be a sign of remodelling.

Availability of data and materials

The datasets used and or analysed during the current study are available from the corresponding author on reasonable request.



Anterior cruciate ligament


Aminoethyl carbazole


Bone-to-bone patellar autograft




Haematoxylin and eosin


Horseradish-peroxidase polymer




Medial collateral ligament


Neurofilament protein


Phosphate-buffered saline


Sensory evoked potentials




  1. Teske W, Anastisiadis A, Lichtinger T, Von Schulze Pellengahr C, Von Engelhardt LV, Theodoridis T. Ruptur des vorderen Kreuzbands. Diagnostik und Therapie Orthopaede. 2010;39(9):883–900.

    CAS  Google Scholar 

  2. Domnick C, Raschke MJ, Herbort M. Biomechanics of the anterior cruciate ligament: physiology, rupture and reconstruction techniques. World J Orthop. 2016;7(2):82.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lobenhoffer P. S1-Leitlinie: Vordere Kreuzbandruptur. S1-Guideline. 2014. Accessed 10/03/2020.

  4. Bradley JP, Klimkiewicz JJ, Rytel MJ, Powell JW. Anterior cruciate ligament injuries in the National Football League: epidemiology and current treatment trends among team physicians. Arthroscopy. 2002;18(5):502–9.

    Article  PubMed  Google Scholar 

  5. Wright RW. Effect of graft choice on the outcome of revision anterior cruciate ligament reconstruction in the multicenter ACL revision study (MARS) cohort. Am J Sports Med. 2014;42(10):2301–10.

    Article  PubMed Central  Google Scholar 

  6. Kim HJ, Lee JH, Lee DH. Proprioception in patients with anterior cruciate ligament tears: a meta-analysis comparing injured and uninjured limbs. Am J Sports Med. 2017;45(12):2916–22.

    Article  PubMed  Google Scholar 

  7. Barrett DS. Proprioception and function after anterior cruciate reconstruction. J Bone Joint Surg (Br). 1991;73(5):833–7.

    Article  CAS  Google Scholar 

  8. Iwasa J, Ochi M, Adachi N, Tobita M, Katsube K, Uchio Y. Proprioceptive improvement in knees with anterior cruciate ligament reconstruction. Clin Orthop Relat Res. 2000;381:168–76.

    Article  Google Scholar 

  9. Ozenci AM, Inanmaz E, Ozcanli H, Soyuncu Y, Samanci N, Dagseven T, et al. Proprioceptive comparison of allograft and autograft anterior cruciate ligament reconstructions. Knee Surg Sport Traumatol Arthrosc. 2007;15(12):1432–7.

    Article  Google Scholar 

  10. Young SW, Valladares RD, Loi F, Dragoo JL. Mechanoreceptor reinnervation of autografts versus allografts after anterior cruciate ligament reconstruction. Orthop J Sport Med. 2016;4(10):1–5.

    Article  Google Scholar 

  11. Kim SH, Chun CH, Chun KC, Jo HJ, Kim KM. Histological assessment of mechanoreceptors in Achilles allografts after anterior cruciate ligament reconstruction. Am J Sports Med. 2012;40(9):2061–5.

    Article  PubMed  Google Scholar 

  12. Bali K, Dhillon MS, Vasistha RK, Kakkar N, Chana R, Prabhakar S. Efficacy of immunohistological methods in detecting functionally viable mechanoreceptors in the remnant stumps of injured anterior cruciate ligaments and its clinical importance. Knee Surg Sport Traumatol Arthrosc. 2012;20(1):75–80.

    Article  Google Scholar 

  13. Hagert E. Differences in the presence of mechanoreceptors and nerve structures between wrist ligaments may imply differential roles in wrist stabilization. J Orthop Res. 2005;23:757–63.

    Article  PubMed  Google Scholar 

  14. Rein S, Hanisch U, Zwipp H, Fieguth A, Lwowski S, Hagert E. Comparative analysis of inter- and intraligamentous distribution of sensory nerve endings in ankle ligaments: a cadaver study. Foot Ankle Int. 2013;34(7):1017–24.

    Article  PubMed  Google Scholar 

  15. Churl Chun K, Hyun Lee S, Woo Kim J, Jung Jin E, Mee Kim K, Hong CC. Immunohistochemical and immunocytochemical study of mechanoreceptors in anterior cruciate ligament reconstruction with the remnant-preserving technique using Achilles tendon allografts. J Orthop Surg Res. 2017;12(93).

  16. Gonzalez-Martinez T, Perez-Piñera P, Díaz-Esnal B, Vega JA. S-100 proteins in the human peripheral nervous system. Microsc Res Tech. 2003;60(6):633–8.

    Article  CAS  PubMed  Google Scholar 

  17. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4(7):517–29.

    Article  CAS  PubMed  Google Scholar 

  18. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun. 2004;322(4):1111–22.

    Article  CAS  PubMed  Google Scholar 

  19. Yamashita T, Fujitani M, Hata K, Mimura F, Yamagishi S. Diverse functions of the p75 neurotrophin receptor. Anat Sci Int. 2005;80:37–41.

    Article  CAS  PubMed  Google Scholar 

  20. Cosgaya JM, Chan JR, Shooter EM. The neurotrophin receptor p75ntr as a positive regulator of myelination. Science (80). 2002;298:1245–8.

    Article  CAS  Google Scholar 

  21. Liang Y, Johansson O. Light and electron microscopic demonstration of the p75 nerve growth factor receptor in normal human cutaneous nerve fibers: new vistas. J Invest Dermatol. 1998;111(1):114–8.

    Article  CAS  PubMed  Google Scholar 

  22. Campbell LK. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol. 2003;16(10):963–9.

    Article  PubMed  Google Scholar 

  23. Bailey JF, Liebenberg E, Degmetich S, Lotz JC. Innervation patterns of PGP 9.5-positive nerve fibers within the human lumbar vertebra. J Anat. 2011;218(3):263–70.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Rein S. Zur Propriozeption des menschlichen Sprunggelenks. Habilitation thesis. Dresden; 2011. p. 48–9.

  25. Day INM, Thompson RJ. UCHL1 (PGP9.5): neuronal biomarker and ubiquitin system protein. Prog Neurobiol. 2010;90(3):327–62.

    Article  CAS  PubMed  Google Scholar 

  26. Freeman MA, Wyke B. The innervation of the knee joint. An anatomical and histological study in the cat. J Anat. 1967;101(Pt 3):505–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Barrack RL, Lund PJ, Munn BG, Wink C, Happel L. Evidence of reinnvervation of free patellar tendon autograft used for anterior cruciate ligament reconstruction. Am J Sports Med. 1997;25(2):196–202.

    Article  CAS  PubMed  Google Scholar 

  28. Fromm B, Kummer W. Nerve supply of anterior cruciate ligaments and of cryopreserved anterior cruciate ligament allografts: a new method for the differentiation of the nervous tissues. Knee Surg Sport Traumatol Arthrosc. 1994;2(2):118–22.

    Article  CAS  Google Scholar 

  29. Wada Y, Takahashi T, Michinaka Y, Morisawa Y, Yamamoto H. Mechanoreceptors of patellar tendon used for ACL reconstruction. Rabbit experiments. Acta Orthop Scand. 1997;68(6):559–62.

    Article  CAS  PubMed  Google Scholar 

  30. Kosy JD, Mandalia VI. Anterior cruciate ligament mechanoreceptors and their potential importance in remnant-preserving reconstruction: a review of basic science and clinical findings. J Knee Surg. 2018;31(8):736–46.

    Article  PubMed  Google Scholar 

  31. Murray MM, Martin SD, Martin TL, Spector M. Histological changes in the human anterior cruciate ligament after rupture. J Bone Jt Surg Am. 2000;82(10):1387–7.

  32. Çabuk H, Kuşku ÇF. Mechanoreceptors of the ligaments and tendons around the knee. Clin Anat. 2016;29(6):789–95.

    Article  PubMed  Google Scholar 

  33. Pauzenberger L, Syré S, Schurz M. “Ligamentization” in hamstring tendon grafts after anterior cruciate ligament reconstruction: a systematic review of the literature and a glimpse into the future. Arthrosc J Arthrosc Relat Surg. 2013;29(10):1712–21.

    Article  Google Scholar 

  34. Janssen RPA, van der Wijk J, Fiedler A, Schmidt T, Sala HAGM, Scheffler SU. Remodelling of human hamstring autografts after anterior cruciate ligament reconstruction. Knee Surg Sport Traumatol Arthrosc. 2011;19(8):1299–306.

    Article  Google Scholar 

  35. Gillquist J, Messner K. Anterior cruciate ligament reconstruction and the long term incidence of gonarthrosis. Sports Med. 1999;27(3):143–56.

    Article  CAS  PubMed  Google Scholar 

  36. Smith TO, Postle K, Penny F, McNamara I, Mann CJV. Is reconstruction the best management strategy for anterior cruciate ligament rupture? A systematic review and meta-analysis comparing anterior cruciate ligament reconstruction versus non-operative treatment. Knee. 2014;21(2):462–70.

    Article  PubMed  Google Scholar 

Download references


Not applicable.


This study was not funded.

Author information

Authors and Affiliations



All authors listed above made substantial contributions to this study and have read the final manuscript. DR: immunohistology, image and data interpretation and wrote the article. HOM: supplied the samples and study design. HS: scientific advice. SHL: immunohistology and imaging. AB: study design, image and data interpretation. The authors read and approved the final manuscript.

Corresponding author

Correspondence to D. Rebmann.

Ethics declarations

Ethics approval and consent to participate

All patients signed the informed consent form, and the use of the specimens was approved by the ethical committee of the Albert-Ludwigs University Freiburg, Germany (application-number: 305/10).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

Ruffini ending (a) and free nerve ending (b). Staining with the anti-p75 antibody.

Additional file 2.

Ruffini ending (a) and free nerve ending (b). Staining with the anti-PGP9.5 antibody.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rebmann, D., Mayr, H.O., Schmal, H. et al. Immunohistochemical analysis of sensory corpuscles in human transplants of the anterior cruciate ligament. J Orthop Surg Res 15, 270 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: